Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

What is the ROI for upgrading nuclear cardiology labs?

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade? 

April 12, 2023

AI predicts the likelihood of a common TAVR complication

Many patients still require a permanent pacemaker following TAVR. In fact, it is more common after TAVR than after surgical aortic valve replacement. 

April 10, 2023
Sunil Rao, MD, FSCAI, 2022-23 President of the Society of Cardiovascular Angiography and Interventions (SCAI), and director of interventional cardiology NYU Langone, explains efforts by SCAI to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers (ASC).

Maintaining quality is key as more cardiac procedures migrate to outpatient ASCs

SCAI President Sunil Rao, MD, discussed the group's efforts to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers.

April 10, 2023
Brain imaging artificial intelligence is a primary area of concentration for AI because oif the critical nature of fast detection and treatment for patients. This is an example of the AI applications displayed by third-party advanced visualization vendor TeraRecon at RSNA 2022.

What is the ROI on AI adoption in radiology?

Radiology makes up the vast majority of FDA-cleared AI algorithms, but with minimal or no reimbursement, hospital administrators may ask whether AI’s value justifies its expense.

April 6, 2023
artificial intelligence AI deep learning

Cardiologists find AI to be more accurate than sonographers at interpreting echocardiograms

Overall, cardiologists made corrections to 16.8% of AI-generated assessments and 27.2% of sonographer assessments.

April 5, 2023
Cardiologist Azeem Latib

Cardiologist Azeem Latib joins Supira Medical

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

April 4, 2023
Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

March 23, 2023
Sahil Parikh explains the tread of cardiology departments treating critical limb ischemia (CLI) at AHA 2022.

Interventional cardiology's role in treating CLI continues to evolve

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

March 2, 2023

Around the web

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Trimed Popup
Trimed Popup